Inclusion body myositis in Alzheimer’s disease-Reference-Cited by-同舟云学术

Inclusion body myositis in Alzheimer’s disease

Published:2010-12-22 Issue:3 Volume:124 Page:215-217
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:

Author:

Roos P. M.,Vesterberg O.,Nordberg M.

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.2010.01461.x/fullpdf

Reference12 articles.

1. Projected neurodegenerative disease mortality in the United States, 1990-2040;Lilienfeld;Neuroepidemiology,1993

2. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group;Lobo;Neurology,2000

3. The worldwide societal costs of dementia: estimates for 2009;Wimo;Alzheimers Dement,2010

4. Inclusion-body myositis and Alzheimer disease. Two sides of the same coin, or different currencies altogether?;Murphy;Neurology,2006

5. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis;Needham;J Clin Neurosci,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Study 5: A 74-Year-Old Man With Dysphagia, Weakness, and Memory Loss;The Journal of Neuropsychiatry and Clinical Neurosciences;2023-07

2. A cross‐sectional study of memory and executive functions in patients with sporadic inclusion body myositis;Muscle & Nerve;2021-10-21

3. References;Overflow Metabolism;2018

4. Effects of Huperzin-A on the Beta-amyloid accumulation in the brain and skeletal muscle cells of a rat model for Alzheimer's disease;Life Sciences;2017-09

5. BACE-1, PS-1 and sAPPβ Levels Are Increased in Plasma from Sporadic Inclusion Body Myositis Patients: Surrogate Biomarkers among Inflammatory Myopathies;Molecular Medicine;2015-01